Form4insider filings, from the source

SEC Form 4 · accession 0001231919-26-000854

Entrada Therapeutics, Inc. · TRDA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Aug 6, 2026
Accepted (ET)
Aug 10, 2026 · 7:52 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001689375

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Aug 6, 2026S10,494$7.00D2,836,098D
Common StockF3,F2Aug 7, 2026S52,317$6.85D2,783,781D
Common StockF4holding———1,093,313IBy 5AM Opportunities I, L.P.

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses